Evidence map›Paper›PMID 27301585›Full record

Observational studyEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016

Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy.

P Benedetti, A M Sefton, M Menegozzo, C Guerriero, G Bordignon, G Da Rin, C Romualdi, G Pellizzer, D M Livermore

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

P BenedettiUnità Operativa di Malattie Infettive e Tropicali, Ospedale San Bortolo, Viale Rodolfi 37, 36100, Vicenza, Italy. paolo.benedetti@ulssvicenza.it.
A M SeftonInstitute of Cell and Molecular Science, Centre for Infectious Disease, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London, E1 2AT, UK.
M MenegozzoLaboratorio di Microbiologia, Ospedale San Bortolo, Viale Rodolfi 37, 36100, Vicenza, Italy.
C GuerrieroLaboratorio di analisi chimico-cliniche e microbiologiche, Nuovo Ospedale Santorso, Via delle Garziere 42, 36014, Santorso, Italy.
G BordignonLaboratorio di analisi chimico-cliniche e microbiologiche, Ospedale San Giacomo Apostolo, Via dei Carpani 16/Z, 31033, Castelfranco, Veneto, Italy.
G Da RinMedicina di laboratorio, Ospedale San Bassiano, Via dei Lotti 40, 36061, Bassano del Grappa, Italy.
C RomualdiServizio di Statistica, Dipartimento di Biologia, Università degli studi di Padova, Via Ugo Bassi 58/B, 35121, Padova, Italy.
G PellizzerUnità Operativa di Malattie Infettive e Tropicali, Ospedale San Bortolo, Viale Rodolfi 37, 36100, Vicenza, Italy.
D M LivermoreNorwich Medical School, University of East Anglia, Norwich Research Park, NR4 7TJ, Norwich, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International - predominantly American - studies undertaken in the ICUs of teaching centres show that inadequate antibiotic therapy increases mortality and length of stay. We sought to ascertain whether this also pertains to smaller ICUs in the Veneto region of north-east Italy. To the best of our knowledge, this is the first such survey in the Veneto area or in Italy as a whole. A retrospective, observational study was performed across five general-hospital ICUs to examine appropriateness of microbiological sampling, empirical antibiotic adequacy, and outcomes. Among 911 patients (mean age, 65.8 years ± 16.2 SD; median ICU stay, 17.0 days [IQR, 8.0-29.0]), 757 (83.1 %) were given empirical antibiotics. Treatment adequacy could be fully assessed in only 212 patients (28.0 %), who received empirical treatment and who had a relevant clinical sample collected at the initiation of this antibiotic (T0). Many other patients only had delayed microbiological investigation of their infections between day 1 and day 10 of therapy. Mortality was significantly higher among the 34.9 % of patients receiving inadequate treatment (48.6 % vs 18.80 %; p < 0.001). Only 32.5 % of combination regimens comprised a broad-spectrum Gram-negative β-lactam plus an anti-MRSA agent, and many combinations were irrational. Inadequate treatment was frequent and was strongly associated with mortality; moreover, there was delayed microbiological investigation of many infections, precluding appropriate treatment modification and de-escalation. Improvements in these aspects and in antibiotic stewardship are being sought.

Indexed as

Microbial Sensitivity TestsAdolescentAdultAgedAged, 80 and overAnti-Infective AgentsBacterial InfectionsFemaleHospitals, GeneralHumansIntensive Care UnitsItalyMaleMiddle AgedRetrospective StudiesSurvival AnalysisAnti-Infective Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.